Terms: = Ovarian cancer AND MALAT1, PRO1073, 378938, Q9UHZ2
29 results:
1. Mechanistic actions of long non-coding RNA malat1 within the ovary and at the feto-maternal interface.
Adu-Gyamfi EA; Cheeran EA; Salamah J; Lee BK
Mol Biol Rep; 2024 Feb; 51(1):301. PubMed ID: 38353828
[TBL] [Abstract] [Full Text] [Related]
2. Long Non-Coding RNAs: Bridging cancer-Associated Thrombosis and Clinical Outcome of ovarian cancer Patients.
Marques IS; Tavares V; Savva-Bordalo J; Rei M; Liz-Pimenta J; de Melo IG; Assis J; Pereira D; Medeiros R
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203310
[TBL] [Abstract] [Full Text] [Related]
3. METTL16 Inhibits the Malignant Progression of Epithelial ovarian cancer through the lncRNA malat1/
Li C; Liu J; Lyu Y; Ling S; Luo Y
Anal Cell Pathol (Amst); 2023; 2023():9952234. PubMed ID: 37927399
[TBL] [Abstract] [Full Text] [Related]
4. Modulation of long non-coding RNAs by resveratrol as a potential therapeutic approach in cancer: A comprehensive review.
Asemi R; Rajabpoor Nikoo N; Asemi Z; Shafabakhsh R; Hajijafari M; Sharifi M; Homayoonfal M; Davoodvandi A; Hakamifard A
Pathol Res Pract; 2023 Jun; 246():154507. PubMed ID: 37196467
[TBL] [Abstract] [Full Text] [Related]
5. Splice-Variant Knock-Out of TGFβ Receptors Perturbates the Proteome of ovarian Carcinoma Cells.
Jacobs Catane L; Moshel O; Smith Y; Davidson B; Reich R
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884451
[TBL] [Abstract] [Full Text] [Related]
6. LncRNA malat1 Facilitates ovarian cancer Progression through Promoting Chemoresistance and Invasiveness in the Tumor Microenvironment.
Mao TL; Fan MH; Dlamini N; Liu CL
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638541
[TBL] [Abstract] [Full Text] [Related]
7. PTCH1-GLI1 Fusion-Positive ovarian Tumor: Report of a Unique Case With Response to Tyrosine Kinase Inhibitor Pazopanib.
Alwaqfi RR; Samuelson MI; Guseva NN; Ouyang M; Bossler AD; Ma D
J Natl Compr Canc Netw; 2021 Sep; 19(9):998-1004. PubMed ID: 34551385
[TBL] [Abstract] [Full Text] [Related]
8. LncRNAs and miRNAs participate in determination of sensitivity of cancer cells to cisplatin.
Taheri M; Shoorei H; Tondro Anamag F; Ghafouri-Fard S; Dinger ME
Exp Mol Pathol; 2021 Dec; 123():104602. PubMed ID: 33422487
[TBL] [Abstract] [Full Text] [Related]
9. LncRNAs in ovarian cancer Progression, Metastasis, and Main Pathways: ceRNA and Alternative Mechanisms.
Braga EA; Fridman MV; Moscovtsev AA; Filippova EA; Dmitriev AA; Kushlinskii NE
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238475
[TBL] [Abstract] [Full Text] [Related]
10. Exercise-mediated downregulation of malat1 expression and implications in primary and secondary cancer prevention.
Paronetto MP; Dimauro I; Grazioli E; Palombo R; Guidotti F; Fantini C; Sgrò P; De Francesco D; Di Luigi L; Capranica L; Caporossi D
Free Radic Biol Med; 2020 Nov; 160():28-39. PubMed ID: 32768573
[TBL] [Abstract] [Full Text] [Related]
11. The Long Non-Coding RNA malat1 Enhances ovarian cancer Cell Stemness by Inhibiting YAP Translocation from Nucleus to Cytoplasm.
Wu X; Wang Y; Zhong W; Cheng H; Tian Z
Med Sci Monit; 2020 May; 26():e922012. PubMed ID: 32433460
[TBL] [Abstract] [Full Text] [Related]
12. Transcriptome analysis reveals overlap in fusion genes in a phase I clinical cohort of TNBC and HGSOC patients treated with buparlisib and olaparib.
Eismann J; Heng YJ; Waldschmidt JM; Vlachos IS; Gray KP; Matulonis UA; Konstantinopoulos PA; Murphy CJ; Nabavi S; Wulf GM
J Cancer Res Clin Oncol; 2020 Feb; 146(2):503-514. PubMed ID: 31745703
[TBL] [Abstract] [Full Text] [Related]
13. Exosomal Metastasis‑Associated Lung Adenocarcinoma Transcript 1 Promotes Angiogenesis and Predicts Poor Prognosis in Epithelial ovarian cancer.
Qiu JJ; Lin XJ; Tang XY; Zheng TT; Lin YY; Hua KQ
Int J Biol Sci; 2018; 14(14):1960-1973. PubMed ID: 30585260
[TBL] [Abstract] [Full Text] [Related]
14. The long non-coding RNA malat1 promotes ovarian cancer progression by regulating RBFOX2-mediated alternative splicing.
Gordon MA; Babbs B; Cochrane DR; Bitler BG; Richer JK
Mol Carcinog; 2019 Feb; 58(2):196-205. PubMed ID: 30294913
[TBL] [Abstract] [Full Text] [Related]
15. Anticancer effects of Rosmarinic acid in OVCAR-3 ovarian cancer cells are mediated via induction of apoptosis, suppression of cell migration and modulation of lncRNA MALAT-1 expression.
Zhang Y; Hu M; Liu L; Cheng XL; Cai J; Zhou J; Wang T
J BUON; 2018; 23(3):763-768. PubMed ID: 30003749
[TBL] [Abstract] [Full Text] [Related]
16. Long non-coding RNA malat1 regulates ovarian cancer cell proliferation, migration and apoptosis through Wnt/β-catenin signaling pathway.
Guo C; Wang X; Chen LP; Li M; Li M; Hu YH; Ding WH; Wang X
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(12):3703-3712. PubMed ID: 29949143
[TBL] [Abstract] [Full Text] [Related]
17. Interaction of E3 Ubiquitin Ligase MARCH7 with Long Noncoding RNA malat1 and Autophagy-Related Protein ATG7 Promotes Autophagy and Invasion in ovarian cancer.
Hu J; Zhang L; Mei Z; Jiang Y; Yi Y; Liu L; Meng Y; Zhou L; Zeng J; Wu H; Jiang X
Cell Physiol Biochem; 2018; 47(2):654-666. PubMed ID: 29794480
[TBL] [Abstract] [Full Text] [Related]
18. malat1 affects ovarian cancer cell behavior and patient survival.
Lin Q; Guan W; Ren W; Zhang L; Zhang J; Xu G
Oncol Rep; 2018 Jun; 39(6):2644-2652. PubMed ID: 29693187
[TBL] [Abstract] [Full Text] [Related]
19. Knockdown of malat1 enhances chemosensitivity of ovarian cancer cells to cisplatin through inhibiting the Notch1 signaling pathway.
Bai L; Wang A; Zhang Y; Xu X; Zhang X
Exp Cell Res; 2018 May; 366(2):161-171. PubMed ID: 29548748
[TBL] [Abstract] [Full Text] [Related]
20. Genomics of a pediatric ovarian fibrosarcoma. Association with the DICER1 syndrome.
Melendez-Zajgla J; Mercado-Celis GE; Gaytan-Cervantes J; Torres A; Gabiño NB; Zapata-Tarres M; Juarez-Villegas LE; Lezama P; Maldonado V; Ruiz-Monroy K; Mendoza-Caamal E
Sci Rep; 2018 Feb; 8(1):3252. PubMed ID: 29459759
[TBL] [Abstract] [Full Text] [Related]
[Next]
